CN109936983A - 用于增强风味的新型组合物 - Google Patents
用于增强风味的新型组合物 Download PDFInfo
- Publication number
- CN109936983A CN109936983A CN201780068986.8A CN201780068986A CN109936983A CN 109936983 A CN109936983 A CN 109936983A CN 201780068986 A CN201780068986 A CN 201780068986A CN 109936983 A CN109936983 A CN 109936983A
- Authority
- CN
- China
- Prior art keywords
- acid
- tart flavour
- guanosine
- consumer goods
- smell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000796 flavoring agent Substances 0.000 title claims abstract description 83
- 235000019634 flavors Nutrition 0.000 title claims abstract description 79
- 239000000203 mixture Substances 0.000 title claims description 31
- 230000002708 enhancing effect Effects 0.000 title claims description 23
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims description 82
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 61
- 235000012976 tarts Nutrition 0.000 claims description 56
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims description 41
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims description 41
- 229940029575 guanosine Drugs 0.000 claims description 41
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 235000019640 taste Nutrition 0.000 claims description 30
- 239000002253 acid Substances 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000012744 reinforcing agent Substances 0.000 claims description 12
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 10
- 235000009508 confectionery Nutrition 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 9
- -1 glycolic Substances 0.000 claims description 9
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 6
- NUCLJNSWZCHRKL-UHFFFAOYSA-N allantoic acid Chemical compound NC(=O)NC(C(O)=O)NC(N)=O NUCLJNSWZCHRKL-UHFFFAOYSA-N 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 229920000642 polymer Polymers 0.000 claims description 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 5
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 claims description 5
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 claims description 5
- 229960005305 adenosine Drugs 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 5
- 239000002537 cosmetic Substances 0.000 claims description 5
- 235000013622 meat product Nutrition 0.000 claims description 5
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 claims description 5
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims description 4
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 4
- 235000005911 diet Nutrition 0.000 claims description 4
- 230000037213 diet Effects 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000011975 tartaric acid Substances 0.000 claims description 4
- 235000002906 tartaric acid Nutrition 0.000 claims description 4
- AAWZDTNXLSGCEK-WYWMIBKRSA-N (-)-quinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1O AAWZDTNXLSGCEK-WYWMIBKRSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 3
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- XFTRTWQBIOMVPK-YFKPBYRVSA-N Citramalic acid Natural products OC(=O)[C@](O)(C)CC(O)=O XFTRTWQBIOMVPK-YFKPBYRVSA-N 0.000 claims description 3
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 claims description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 3
- 235000010675 chips/crisps Nutrition 0.000 claims description 3
- XFTRTWQBIOMVPK-UHFFFAOYSA-N citramalic acid Chemical compound OC(=O)C(O)(C)CC(O)=O XFTRTWQBIOMVPK-UHFFFAOYSA-N 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 235000006408 oxalic acid Nutrition 0.000 claims description 3
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims description 3
- 229940107700 pyruvic acid Drugs 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 229920000877 Melamine resin Polymers 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 229920002396 Polyurea Polymers 0.000 claims description 2
- 229920001807 Urea-formaldehyde Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 claims description 2
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- IVJISJACKSSFGE-UHFFFAOYSA-N formaldehyde;1,3,5-triazine-2,4,6-triamine Chemical compound O=C.NC1=NC(N)=NC(N)=N1 IVJISJACKSSFGE-UHFFFAOYSA-N 0.000 claims description 2
- 229920000058 polyacrylate Polymers 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 229920000728 polyester Polymers 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- ODGAOXROABLFNM-UHFFFAOYSA-N polynoxylin Chemical compound O=C.NC(N)=O ODGAOXROABLFNM-UHFFFAOYSA-N 0.000 claims description 2
- 229920002635 polyurethane Polymers 0.000 claims description 2
- 239000004814 polyurethane Substances 0.000 claims description 2
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 claims description 2
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 claims description 2
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims 2
- 229940097043 glucuronic acid Drugs 0.000 claims 2
- 244000215068 Acacia senegal Species 0.000 claims 1
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 229920000084 Gum arabic Polymers 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 239000000205 acacia gum Substances 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 229920002401 polyacrylamide Polymers 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 abstract description 6
- 230000003014 reinforcing effect Effects 0.000 abstract description 5
- 125000003835 nucleoside group Chemical group 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 36
- 238000012360 testing method Methods 0.000 description 27
- 239000002585 base Substances 0.000 description 18
- 239000000523 sample Substances 0.000 description 18
- RQFCJASXJCIDSX-UHFFFAOYSA-N 14C-Guanosin-5'-monophosphat Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(COP(O)(O)=O)C(O)C1O RQFCJASXJCIDSX-UHFFFAOYSA-N 0.000 description 17
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 17
- 235000002639 sodium chloride Nutrition 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000012488 sample solution Substances 0.000 description 14
- 229930024421 Adenine Natural products 0.000 description 12
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 12
- 229960000643 adenine Drugs 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 235000019658 bitter taste Nutrition 0.000 description 11
- 229930182470 glycoside Natural products 0.000 description 11
- 150000002338 glycosides Chemical class 0.000 description 11
- 235000019605 sweet taste sensations Nutrition 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 9
- 244000192528 Chrysanthemum parthenium Species 0.000 description 8
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 8
- 235000008384 feverfew Nutrition 0.000 description 8
- 210000000697 sensory organ Anatomy 0.000 description 8
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 241000533293 Sesbania emerus Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 229940069765 bean extract Drugs 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 244000185386 Thladiantha grosvenorii Species 0.000 description 3
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000013923 monosodium glutamate Nutrition 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 235000021565 orange beverage Nutrition 0.000 description 3
- 229960000395 phenylpropanolamine Drugs 0.000 description 3
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 3
- 235000013606 potato chips Nutrition 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 3
- 235000019202 steviosides Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- 244000141009 Hypericum perforatum Species 0.000 description 2
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 240000008866 Ziziphus nummularia Species 0.000 description 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013902 inosinic acid Nutrition 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- XNLFIERPGXTDDP-UHFFFAOYSA-N periandrin i Chemical compound C1CC(C2C(C3(CCC4(C)CCC(C)(C=C4C3CC2)C(O)=O)C)(C)CC2)(C=O)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O XNLFIERPGXTDDP-UHFFFAOYSA-N 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 235000011962 puddings Nutrition 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 description 2
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- CAVQBDOACNULDN-NRCOEFLKSA-N (1s,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-NRCOEFLKSA-N 0.000 description 1
- NKQJVOJUSQJZPX-QMMMGPOBSA-N (2S)-3-(3,4-dihydroxyphenyl)-2-(ethylamino)propanoic acid Chemical compound CCN[C@@H](Cc1ccc(O)c(O)c1)C(O)=O NKQJVOJUSQJZPX-QMMMGPOBSA-N 0.000 description 1
- QZOALWMSYRBZSA-PDSBIMDKSA-N (3r,5r,8r,9r,10r,13s,14r)-3-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-17-[(1s)-1-[(2r,5s,6r)-5-methyl-6-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1C[C@H]2C(=O)C[C@@H]3[C@H]4CCC([C@]4(CC[C@H]3[C@@]2(C)CC1)C)[C@H](C)[C@@H]1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-PDSBIMDKSA-N 0.000 description 1
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- BCXHDORHMMZBBZ-DORFAMGDSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;sulfuric acid Chemical compound OS(O)(=O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC BCXHDORHMMZBBZ-DORFAMGDSA-N 0.000 description 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- WFXURHIXPXVPGM-UHFFFAOYSA-N 2,3-dihydroxybutanedioic acid;2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine Chemical compound OC(=O)C(O)C(O)C(O)=O.C1N(C)CCC(C2=CC=CC=C22)=C1C2C1=CC=CC=C1 WFXURHIXPXVPGM-UHFFFAOYSA-N 0.000 description 1
- DJIOGHZNVKFYHH-UHFFFAOYSA-N 2-hexadecylpyridine Chemical compound CCCCCCCCCCCCCCCCC1=CC=CC=N1 DJIOGHZNVKFYHH-UHFFFAOYSA-N 0.000 description 1
- NNXQSUSEFPRCRS-YCKMUKMSSA-N 3-[(3S,3aR,4R,5aR,6S,7S,9aR,9bR)-3-[(E,2S)-2,6-dihydroxy-6-methylhept-4-en-2-yl]-6,9a,9b-trimethyl-7-prop-1-en-2-yl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,3a,4,5,5a,7,8,9-decahydrocyclopenta[a]naphthalen-6-yl]propanoic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1[C@@H]2[C@@H]([C@@](C)(O)C\C=C\C(C)(C)O)CC[C@@]2(C)[C@]2(C)CC[C@@H](C(C)=C)[C@](C)(CCC(O)=O)[C@H]2C1 NNXQSUSEFPRCRS-YCKMUKMSSA-N 0.000 description 1
- ICJBMWOVLFPLFP-UHFFFAOYSA-N 4-[2-(bromomethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene Chemical compound COCCCOC1=CC(CC(CBr)C(C)C)=CC=C1OC ICJBMWOVLFPLFP-UHFFFAOYSA-N 0.000 description 1
- 244000144619 Abrus precatorius Species 0.000 description 1
- CJHYXUPCGHKJOO-GUESNGNRSA-N Abrusoside A Natural products O=C(O)[C@]1(C)[C@@H](O[C@@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)CC[C@@]23[C@H]1CC[C@H]1[C@@]4(C)[C@@](C)([C@H]([C@@H](C)[C@H]5OC(=O)C(C)=CC5)CC4)CC[C@@]21C3 CJHYXUPCGHKJOO-GUESNGNRSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DJHSXYPMGGWLLQ-UHFFFAOYSA-N BrC1=CC=CC=C1.C(C=C/C(=O)O)(=O)O Chemical compound BrC1=CC=CC=C1.C(C=C/C(=O)O)(=O)O DJHSXYPMGGWLLQ-UHFFFAOYSA-N 0.000 description 1
- 235000017336 Capparis spinosa Nutrition 0.000 description 1
- 244000140995 Capparis spinosa Species 0.000 description 1
- XYGSFNHCFFAJPO-UHFFFAOYSA-N Chlophedianol hydrochloride Chemical compound Cl.C=1C=CC=C(Cl)C=1C(O)(CCN(C)C)C1=CC=CC=C1 XYGSFNHCFFAJPO-UHFFFAOYSA-N 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 229920001268 Cholestyramine Polymers 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 239000001836 Dioctyl sodium sulphosuccinate Substances 0.000 description 1
- KBAUFVUYFNWQFM-UHFFFAOYSA-N Doxylamine succinate Chemical compound OC(=O)CCC(O)=O.C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 KBAUFVUYFNWQFM-UHFFFAOYSA-N 0.000 description 1
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 description 1
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 239000001776 FEMA 4720 Substances 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- HYQNKKAJVPMBDR-HIFRSBDPSA-N Hernandulcin Chemical compound CC(C)=CCC[C@](C)(O)[C@@H]1CCC(C)=CC1=O HYQNKKAJVPMBDR-HIFRSBDPSA-N 0.000 description 1
- HYQNKKAJVPMBDR-UHFFFAOYSA-N Hernandulcin Natural products CC(C)=CCCC(C)(O)C1CCC(C)=CC1=O HYQNKKAJVPMBDR-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- QZOALWMSYRBZSA-UHFFFAOYSA-N Osladin Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O QZOALWMSYRBZSA-UHFFFAOYSA-N 0.000 description 1
- DLUTTXMPJCVUFR-HJCIYZGTSA-N Parillin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1C[C@H]2CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@@H](C)CC1)O5)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DLUTTXMPJCVUFR-HJCIYZGTSA-N 0.000 description 1
- 101000865553 Pentadiplandra brazzeana Defensin-like protein Proteins 0.000 description 1
- SSOXZAQUVINQSA-BTJKTKAUSA-N Pheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=CC=C1 SSOXZAQUVINQSA-BTJKTKAUSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 201000011252 Phenylketonuria Diseases 0.000 description 1
- DYWNLSQWJMTVGJ-KUSKTZOESA-N Phenylpropanolamine hydrochloride Chemical compound Cl.C[C@H](N)[C@H](O)C1=CC=CC=C1 DYWNLSQWJMTVGJ-KUSKTZOESA-N 0.000 description 1
- IOUVKUPGCMBWBT-DARKYYSBSA-N Phloridzin Natural products O[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-DARKYYSBSA-N 0.000 description 1
- 241000592274 Polypodium vulgare Species 0.000 description 1
- OFFJUHSISSNBNT-UHFFFAOYSA-N Polypodoside A Natural products C1CC(C)C(OC2C(C(O)C(O)C(C)O2)O)OC1C(C)C(C1(CCC2C3(C)CC4)C)CCC1C2=CC(=O)C3CC4OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O OFFJUHSISSNBNT-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- RLLCWNUIHGPAJY-RYBZXKSASA-N Rebaudioside E Natural products O=C(O[C@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)[C@@H](O)[C@@H](O)[C@H](CO)O1)[C@]1(C)[C@@H]2[C@@](C)([C@@H]3[C@@]4(CC(=C)[C@@](O[C@@H]5[C@@H](O[C@@H]6[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O6)[C@H](O)[C@@H](O)[C@H](CO)O5)(C4)CC3)CC2)CCC1 RLLCWNUIHGPAJY-RYBZXKSASA-N 0.000 description 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 description 1
- 235000001535 Ribes X utile Nutrition 0.000 description 1
- 235000016919 Ribes petraeum Nutrition 0.000 description 1
- 244000281247 Ribes rubrum Species 0.000 description 1
- 235000002355 Ribes spicatum Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 240000003377 Shepherdia canadensis Species 0.000 description 1
- 235000018324 Shepherdia canadensis Nutrition 0.000 description 1
- 241001409321 Siraitia grosvenorii Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- RMBMLYUFYBZPCX-DZPSSIEHSA-N Trifloroside Natural products O=C(OC[C@H]1[C@@H](OC(=O)c2c(O)c(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O3)ccc2)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@H](O[C@H]2[C@@H](C=C)[C@H]3C(C(=O)OCC3)=CO2)O1)C RMBMLYUFYBZPCX-DZPSSIEHSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- VMRGPCWYQLQNRB-ZHRVIQQSSA-N [(2S,3R,4S,5S,6R)-6-[[(2R,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate Chemical compound C[C@@]12CCC[C@](C)([C@H]1CC[C@@]13CC(=C)[C@@](C1)(CC[C@@H]23)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)O[C@@H]1O[C@H](CO[C@]2(CO)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@H]1O VMRGPCWYQLQNRB-ZHRVIQQSSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- CJHYXUPCGHKJOO-AYOTXDKCSA-N abrusoside A Chemical compound O([C@H]1CC[C@@]23[C@H]([C@]1(C)C(O)=O)CC[C@H]1[C@]4(C)CC[C@@H]([C@]4(CC[C@]12C3)C)[C@H](C)[C@H]1OC(=O)C(C)=CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CJHYXUPCGHKJOO-AYOTXDKCSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940002273 anbesol Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229960002708 antigout preparations Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GXDALQBWZGODGZ-UHFFFAOYSA-N astemizole Chemical compound C1=CC(OC)=CC=C1CCN1CCC(NC=2N(C3=CC=CC=C3N=2)CC=2C=CC(F)=CC=2)CC1 GXDALQBWZGODGZ-UHFFFAOYSA-N 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- JOKKBOSZTVHKSH-UHFFFAOYSA-N baiyunoside Natural products CC12CCC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C(C)(C)C1CCC(C)=C2CCC=1C=COC=1 JOKKBOSZTVHKSH-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WGGCPZGVZUALQV-UHFFFAOYSA-N benzene;propan-1-amine Chemical compound CCCN.C1=CC=CC=C1 WGGCPZGVZUALQV-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 229950002342 bisfentidine Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 235000012174 carbonated soft drink Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 229960001769 chlorcyclizine hydrochloride Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 229960003871 codeine sulfate Drugs 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000014156 coffee whiteners Nutrition 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 235000004634 cranberry Nutrition 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229930193831 cyclocarioside Natural products 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 229960001985 dextromethorphan Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 229960005008 doxylamine succinate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229940053650 focalin Drugs 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013905 glycine and its sodium salt Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- ZQDWXGKKHFNSQK-UHFFFAOYSA-N hydroxyzine Chemical compound C1CN(CCOCCO)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZQDWXGKKHFNSQK-UHFFFAOYSA-N 0.000 description 1
- 229960000930 hydroxyzine Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229940095990 inderal Drugs 0.000 description 1
- 230000000053 inderal effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000021539 instant coffee Nutrition 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 235000020162 malted milk drink Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000015090 marinades Nutrition 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- GFEGEDUIIYDMOX-BMJUYKDLSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(z)-3-[[(z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-hydroxypent-2-en-3-yl]disulfanyl]-5-hydroxypent-2-en-2-yl]formamide Chemical compound C=1N=C(C)N=C(N)C=1CN(C=O)C(\C)=C(CCO)/SSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N GFEGEDUIIYDMOX-BMJUYKDLSA-N 0.000 description 1
- FXJAOWANXXJWGJ-UHFFFAOYSA-N n-[4-(2-methyl-1h-imidazol-5-yl)phenyl]-n'-propan-2-ylmethanimidamide Chemical compound C1=CC(NC=NC(C)C)=CC=C1C1=CN=C(C)N1 FXJAOWANXXJWGJ-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960003956 phenindamine tartrate Drugs 0.000 description 1
- 229960001339 pheniramine maleate Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960002305 phenylpropanolamine hydrochloride Drugs 0.000 description 1
- IZRPKIZLIFYYKR-UHFFFAOYSA-N phenyltoloxamine Chemical compound CN(C)CCOC1=CC=CC=C1CC1=CC=CC=C1 IZRPKIZLIFYYKR-UHFFFAOYSA-N 0.000 description 1
- 229960001526 phenyltoloxamine Drugs 0.000 description 1
- FAASKPMBDMDYGK-UHFFFAOYSA-N phlomisoside I Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1C(C)(C)C(CCC(C)=C2CCC3=COC=C3)C2(C)CC1 FAASKPMBDMDYGK-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 description 1
- IOUVKUPGCMBWBT-QNDFHXLGSA-N phlorizin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-QNDFHXLGSA-N 0.000 description 1
- 235000019139 phlorizin Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 150000003085 polypodoside A derivatives Polymers 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 1
- BALXUFOVQVENIU-KXNXZCPBSA-N pseudoephedrine hydrochloride Chemical compound [H+].[Cl-].CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-KXNXZCPBSA-N 0.000 description 1
- 229960003447 pseudoephedrine hydrochloride Drugs 0.000 description 1
- 229960004159 pseudoephedrine sulfate Drugs 0.000 description 1
- NNXQSUSEFPRCRS-UHFFFAOYSA-N pterocaryoside A Natural products OC1C(O)C(O)C(C)OC1OC1C2C(C(C)(O)CC=CC(C)(C)O)CCC2(C)C2(C)CCC(C(C)=C)C(C)(CCC(O)=O)C2C1 NNXQSUSEFPRCRS-UHFFFAOYSA-N 0.000 description 1
- SODWWCZKQRRZTG-UHFFFAOYSA-N pterocaryoside B Natural products OC(=O)CCC1(C)C(C(=C)C)CCC(C2(CCC(C22)C(C)(O)CC=CC(C)(C)O)C)(C)C1CC2OC1OCC(O)C(O)C1O SODWWCZKQRRZTG-UHFFFAOYSA-N 0.000 description 1
- 239000002212 purine nucleoside Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 description 1
- QRGRAFPOLJOGRV-UHFFFAOYSA-N rebaudioside F Natural products CC12CCCC(C)(C1CCC34CC(=C)C(CCC23)(C4)OC5OC(CO)C(O)C(OC6OCC(O)C(O)C6O)C5OC7OC(CO)C(O)C(O)C7O)C(=O)OC8OC(CO)C(O)C(O)C8O QRGRAFPOLJOGRV-UHFFFAOYSA-N 0.000 description 1
- HYLAUKAHEAUVFE-AVBZULRRSA-N rebaudioside f Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)CO1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HYLAUKAHEAUVFE-AVBZULRRSA-N 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- FJPYVLNWWICYDW-UHFFFAOYSA-M sodium;5,5-diphenylimidazolidin-1-ide-2,4-dione Chemical compound [Na+].O=C1[N-]C(=O)NC1(C=1C=CC=CC=1)C1=CC=CC=C1 FJPYVLNWWICYDW-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229960001385 thiamine disulfide Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- RMBMLYUFYBZPCX-XQARLGSBSA-N trifloroside Chemical compound CC(=O)OC[C@H]1O[C@@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(=O)c1cccc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1O RMBMLYUFYBZPCX-XQARLGSBSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/23—Synthetic spices, flavouring agents or condiments containing nucleotides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
- A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
- A23L13/428—Addition of flavours, spices, colours, amino acids or their salts, peptides, vitamins, yeast extract or autolysate, nucleic acid or derivatives, organic acidifying agents or their salts or acidogens, sweeteners, e.g. sugars or sugar alcohols; Addition of alcohol-containing products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
- A23L19/12—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops of potatoes
- A23L19/18—Roasted or fried products, e.g. snacks or chips
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/54—Mixing with gases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/12—Natural spices, flavouring agents or condiments; Extracts thereof from fruit, e.g. essential oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/82—Acid flavourants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Seasonings (AREA)
- Confectionery (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及核碱基或核苷在消费品中提供味道特异性增强效果的用途。
Description
相关申请的状态
本申请要求2016年11月16日提交的美国临时专利申请号62/422,633的优先权,其全部内容在此通过引用并入本文作为参考。
发明领域
本发明涉及用于增强消费品的酸味、令人垂涎的味道和多汁感以及新鲜感的新型组合物和方法。
背景技术
食品工业为改变和调和食品中的味道做出了巨大努力。味道的基本类别包括咸味、甜味、酸味、苦味和鲜味。发现改变这些基本味道的新味道改良剂能够产生所需的口味。然而,目前可用的味道改良剂通常是非选择性的,因此,整体味道的品质可被改变。因此,特别需要开发提供风味特异性改性效果的味道改良剂。这些化合物选择性地改变特定类型的味道而不影响产品中的其他风味。
发明概述
本发明提供了使用核碱基鸟嘌呤,其相应的核苷鸟嘌呤核苷或其混合物来增强消费品中的酸味的新方法。
在一个实施方案中,本发明涉及一种增强消费品的酸味的方法,该方法包括向消费品中添加嗅觉有效量的鸟嘌呤、鸟嘌呤核苷或其混合物。
在另一个实施方案中,本发明涉及包含嗅觉有效量的鸟嘌呤、鸟嘌呤核苷或其混合物和可食用酸(consumable acid)的组合。
在另一个实施方案中,本发明涉及含有嗅觉有效量的鸟嘌呤、鸟嘌呤核苷或其混合物和可食用酸的消费品。
通过阅读以下说明书,本发明的这些和其他实施方案将变得显而易见。
发明详述
酸味促进消费品的生津和垂涎感,并提供多汁和新鲜感。通常,使用可食用酸来赋予酸味。然而,酸的使用降低了pH水平,并因此可能导致消费品不希望的质地变化以及成分降解。据报道,高酸性食物也与多种健康问题有关。此外,目前可用的味道改良剂通常是非选择性的,因此,整体味道的品质可被改变。因此,仍然需要新的味道增强剂,其在没有负面的香气或味道属性的情况下可增强消费品的酸味,且不改变pH水平并且不影响其他风味。
众所周知,核苷衍生物以及核苷酸如5'-核苷酸包括肌苷单磷酸(IMP)、腺苷5'-单磷酸(AMP)和鸟嘌呤核苷5'-单磷酸(GMP)可提供鲜味或咸味(Fuke,et al.(1993)Trendsin Food Science and Technology 4:246–251)。然而,甚少涉及核碱基和核苷的风味使用方面。迄今为止,仅报道了腺苷可增强甜味,这可能与其α-葡糖苷酶抑制作用有关(EP0738475A1;WO2013/143822)。现在出人意料地发现,核碱基鸟嘌呤及其相应的核苷鸟嘌呤核苷选择性地增强了消费品的酸味、垂涎感、多汁感和新鲜感。鸟嘌呤和鸟嘌呤核苷可商购获得,根据本领域已知的方法合成(例如美国专利号6,242,599和3,332,935中所述),或由细菌菌株或各种植物(botanicals)产生。它们可以产自例如但不限于St.John’s Wort(Hypericum perforatum)、蔓越莓、莴苣、菊苣、大枣、猕猴桃、茄瓜、枣、黑醋栗、金银花、马黛茶、葱、油菜花粉、番茄、牛奶、当归(Dong Quai)、罗汉果(Luo Han Guo)、蜂蜜、虫草(Ophiocordyceps sinensis)、肉制品、木耳、酵母、蘑菇、鱼和其他海鲜。
消费品包括例如食品、药用组合物、膳食补充剂、营养保健品、牙科卫生组合物和化妆品。消费品可进一步含有调味剂。
在一些实施方案中,消费品是食品,包括例如但不限于水果;蔬菜;果汁;肉制品如火腿、培根和香肠;蛋制品;水果浓缩物;明胶和明胶样产品,例如果酱、果冻、蜜饯等;奶制品,如酸奶,冰淇淋,酸奶油和冰冻果子露;糖衣;糖浆,包括糖蜜;玉米;小麦;黑麦;大豆;燕麦;大米和大麦制品;坚果肉和坚果制品;谷物;爆米花;蛋糕;饼干;虾片;薯片、布丁;糖果和营养棒糖果,如糖果、胶糖、水果味糖、巧克力、口香糖、薄荷糖;奶酪;酱汁;蘸酱;调味品;调料;肉汁;腌泡汁;馅料;糖霜;浇头;奶油;馅饼和面包。在某个实施方案中,食品是饮料,包括例如但不限于咖啡;茶;碳酸软饮料,例如COKE和PEPSI;非碳酸软饮料和其他水果饮料;运动饮料,例如GATORADE;酒精饮料如啤酒,葡萄酒和烈酒。消费品还包括制备的包装产品,例如颗粒状风味混合物,其在用水重构时提供非碳酸饮料;速溶布丁混合物;速溶咖啡和茶;咖啡增白剂;麦芽乳混合物;宠物食品;牲畜饲料;烟草和用于烘焙应用的材料,例如用于制备面包、饼干、蛋糕、薄饼、甜甜圈等的粉末烘焙混合物。消费品还包括含有少量或不含蔗糖的饮食或低热量食品和饮料。优选的消费品包括碳酸饮料。消费品还包括调味品,例如药草、香料和调味料、增味剂(例如谷氨酸钠)、饮食甜味剂和液体甜味剂。
在其他实施方案中,消费品是药用组合物、膳食补充剂、营养保健品、牙科卫生组合物或化妆品。优选的组合物是含有柚皮素,一种或多种药学上可接受的赋形剂和一种或多种活性剂的药用组合物,所述活性剂具有除甜味增强之外的生物学作用。这些活性剂包括具有除味道增强之外的活性的药物和生物制剂。这些活性剂在本领域中是公知的(参见,例如,The Physician's Desk Reference)。此类组合物可根据本领域已知的方法制备,例如Remington's Pharmaceutical Sciences,Mack Publishing Co.,Easton,PA中所述。在一个实施方案中,这种活性剂包括支气管扩张剂、厌食剂、抗组胺剂、营养补充剂、缓泻剂、止痛剂、麻醉剂、抗酸剂、H2受体拮抗剂、抗胆碱能剂、止泻剂、镇痛剂、止咳剂、抗抑郁剂、抗微生物剂、抗菌剂、抗真菌剂、抗病毒剂、祛痰剂、抗炎剂、解热剂及其混合物。在另一个实施方案中,活性剂选自以下组成的组:解热镇痛药(antipyretic and analgesic),例如布洛芬、对乙酰氨基酚或阿司匹林;缓泻剂,例如酚酞二辛基磺基琥珀酸钠;食欲抑制剂,例如苯丙胺、苯丙醇胺、苯丙醇胺盐酸盐或咖啡因;抗酸剂,例如碳酸钙;抗哮喘剂,例如茶碱;止泻剂,例如二苯氧基盐酸盐;抗胃肠胀气剂,例如二甲基硅油(simethecon);偏头痛药,例如酒石酸麦角胺;精神药理学药剂,例如氟哌啶醇;解痉或镇静剂,例如苯巴比妥;抗多动症药剂,例如甲基多巴或哌醋甲酯;镇静剂,例如苯并二氮、羟嗪、甲磺酸盐或吩噻嗪;抗组胺药,例如阿司咪唑、马来酸氯苯那敏、马来酸吡拉明、琥珀酸多西拉敏、马来酸溴苯那敏、柠檬酸苯托沙敏、盐酸氯环嗪、马来酸非尼拉敏或酒石酸苯茚胺;减充血剂,例如盐酸苯丙醇胺、盐酸苯肾上腺素、盐酸伪麻黄碱、硫酸伪麻黄碱、酒石酸苯丙醇胺或麻黄碱;β-受体阻滞剂,例如心得安;酒精戒断剂,例如二硫胺;止咳药,例如苯佐卡因、右美沙芬、右美沙芬氢溴酸盐、诺斯卡品、柠檬酸卡贝他汀和敌退咳;氟补充剂,例如氟化钠;局部抗生素,例如四环素或克林霉素;皮质类固醇补充剂,例如泼尼松或泼尼松龙;抗痛风的药剂,例如秋水仙碱或别嘌呤醇;抗癫痫药,例如苯妥英钠;抗脱水剂,例如电解质补充剂;防腐剂,例如氯化十六烷基吡啶;NSAID,例如对乙酰氨基酚、布洛芬、萘普生或其盐;胃肠道活性剂,例如洛哌丁胺和法莫替丁;生物碱,例如磷酸可待因、硫酸可待因或吗啡;微量元素补充剂,例如氯化钠、氯化锌、碳酸钙、氧化镁和其他碱金属盐和碱土金属盐;维生素;离子交换树脂,例如消胆胺;降胆固醇和降脂物质;抗心律失常药,例如N-乙酰基哌嗪酰胺;祛痰剂,例如愈创甘油醚。膳食补充剂或营养剂的实例包括,例如但不限于用于治疗营养缺乏、创伤、手术、克罗恩病、肾病、高血压、肥胖等的肠内营养产品,以促进运动表现,肌肉增强或一般健康或先天性代谢障碍,如苯丙酮尿症。特别地,这种组合物可含有一种或多种具有苦味或金属味或余味的氨基酸。这些氨基酸包括例如但不限于必需的氨基酸,例如亮氨酸的L异构体、异亮氨酸、组氨酸、赖氨酸、甲硫氨酸、苯丙氨酸、苏氨酸、色氨酸、酪氨酸和缬氨酸。牙科卫生组合物是本领域已知的,包括例如但不限于牙膏、漱口水、牙菌斑冲洗剂、牙线、牙齿止痛剂(例如ANBESOL)等。在一个实施方案中,牙齿卫生组合物包含一种天然甜味剂。在另一个实施方案中,牙齿卫生组合物包含一种以上的天然甜味剂。在另一个实施方案中,牙齿卫生组合物包括蔗糖和玉米糖浆,或蔗糖和阿斯巴甜。化妆品包括例如但不限于面霜、唇膏、唇彩等。用于本发明的其它合适的化妆品包括护唇膏,例如CHAPSTICK或BURT'S BEESWAX Lip Balm。
在一些实施方案中,调味剂包括例如但不限于天然甜味#2(WO2012/129451)、甜菊苷、莱鲍迪甙A、莱鲍迪甙B、莱鲍迪甙C、莱鲍迪甙D、莱鲍迪甙E、莱鲍迪甙F、杜克甙A、杜克甙B、甜叶菊、α-葡糖基甜菊糖、果糖基甜菊糖、半乳糖甜菊糖、β-葡糖基甜菊糖、赛门苷、罗汉果苷IV、罗汉果苷V、罗汉果甜味剂、莫纳甜及其盐、甘草酸及其盐(如、发现于MAGNASWEET)、仙茅素、奇异果甜蛋白、应乐果甜蛋白、马槟榔、布拉齐因(brazzein)、贺兰甜精(hernandulcin)、叶甘素、菝葜苷、根皮苷、三叶苷、白云参苷(baiyunoside)、欧亚水龙骨甜素(osladin)、聚波朵苷A(polypodoside A)、蝶卡苷A(pterocaryoside A)、蝶卡苷B(pterocaryoside B)、无患子倍半萜苷(mukurozioside)、假秦艽苷I(phlomisoside I)、甘草苷I(periandrin I)、相思子三萜苷A(abrusoside A)、青钱柳苷I(cyclocarioside I)、或它们的组合。
可食用酸是一种在给定量下可食用或适合人类食用(human consumption)的酸。可食用酸包括,例如但不限于,乙酸、尿囊酸、α-酮基戊二酸、抗坏血酸、天冬氨酸、苯甲酸、十六酸十八酸混合物(cetostearic acid)、柠苹酸、柠檬酸、甲酸、富马酸、半乳糖醛酸、葡糖醛酸、谷氨酸、甘油酸、乙醇酸、盐酸、异柠檬酸、乳酸、lactarimic acid、乳酸异柠檬酸、苹果酸、草酰乙酸、草酸、磷酸、焦谷氨酸、吡咯烷酮羧酸、丙酮酸、奎尼酸、莽草酸、琥珀酸、硫酸和酒石酸。本发明的可食用酸对消费品的酸味作出贡献。
酸味增强剂应理解为意指化合物本身不具有酸味但可增加和/或延长消费品的酸味。本发明的酸味增强剂是指鸟嘌呤、鸟嘌呤核苷或其混合物。本发明的酸味增强剂增强了消费品的酸味、垂涎感、多汁感和新鲜感。
术语“嗅觉有效量”应理解为意指消费品中使用的酸味增强化合物的量,其中酸味增强化合物增加和/或延长消费品的酸味。
嗅觉有效量可以根据许多因素而变化,包括其他成分、它们的相对量和所需的嗅觉效果。可以使用任何量的酸味增强化合物,只要其提供所需程度的酸味增强效果而不表现出异味。在某些实施方案中,嗅觉有效量的范围以重量计为约0.1ppt至约500ppm,更优选以重量计为约0.1ppb至约50ppm,甚至更优选以重量计为约1ppb至约5ppm。术语“ppt”应理解为以重量计万亿分之一。术语“ppb”应理解为是指以重量计十亿分之十。术语“ppm”应理解为是指以重量计百万分之一。
另外的材料也可以与本发明的化合物结合使用以包封和/或递送酸味增强效果。一些众所周知的材料是,例如但不限于聚合物;低聚物;其他非聚合物如表面活性剂;乳化剂;脂类,包括脂肪、蜡和磷脂;有机油;矿物油;凡士林;天然油;香料固定剂;纤维;淀粉;糖和固体表面材料,如沸石和二氧化硅。一些优选的聚合物包括聚丙烯酸酯;聚脲;聚氨酯;聚丙烯酰胺;聚酯;聚醚;聚酰胺;聚(丙烯酸酯-共-丙烯酰胺);淀粉;二氧化硅;明胶和阿拉伯树胶;藻酸盐;壳聚糖;聚丙交酯;聚(三聚氰胺-甲醛);聚(脲-甲醛);或其组合。
通过以下非限制性实施例更详细地描述本发明。除非另有说明,否则材料均购自Sigma-Aldrich。
实施例I:酸味的增强
在水中的鸟嘌呤(1ppm)被描述为有点涩(astringent),使口腔干燥并具有糊嘴感。在水中的鸟嘌呤核苷(1ppm)被描述为有点涩,使口腔干燥并微苦。鸟嘌呤和鸟嘌呤核苷都没有酸味。随后检测了鸟嘌呤和鸟嘌呤核苷对酸味的增强作用。制备柠檬酸(HOC(COOH)(CH2COOH)2)在水中的基础溶液(400ppm),并用于本发明的以下实施例中。制备鸟嘌呤和鸟嘌呤核苷在基础溶液(分别为5和100ppb)中的测试样品溶液。
将样品对(基础溶液和测试样品溶液)以盲测和伪随机顺序提供给感官小组。基于专门小组成员给出的百分比(给样品酸味的打分)记录酸味的增强。使用二项式统计分析来比较每个样品对的酸味增强。显著性为95%置信区间(p<0.05)。测试结果如下:
样品溶液 | 结果 | p值 |
鸟嘌呤(5ppb) | 比基础溶液更酸 | <0.01<sup>*</sup> |
鸟嘌呤(100ppb) | 比基础溶液更酸 | <0.01<sup>*</sup> |
鸟嘌呤核苷(5ppb) | 比基础溶液更酸 | <0.01<sup>*</sup> |
鸟嘌呤核苷(100ppb) | 比基础溶液更酸 | <0.01<sup>*</sup> |
*鸟嘌呤和鸟嘌呤核苷提供强烈和持久的酸味增强。
实施例II:鸟嘌呤对其他基础味道的影响
检测并比较鸟嘌呤及其核碱基类似物腺嘌呤对其他基础味道的影响。对照溶液的制备如下:
(i)蔗糖在水中的甜味对照溶液(2.5重量%);
(ii)咖啡因在水中的苦味对照溶液(0.05重量%);
(iii)氯化钠在水中的盐对照溶液(0.3重量%);和
(iv)谷氨酸钠(MSG)在水中的鲜味对照溶液(0.05重量%)。
以不同的对照溶液(2或20ppm)制备腺嘌呤和鸟嘌呤的各测试溶液。
通过一组专门小组成员使用0至10的强度等级来评估每个样品的味觉,其中0=无,5=中等,10=极强。指示专门小组成员将对照溶液的强度固定为等级5。使用具有PostHoc LSD多重比较的单向ANOVA分析强度评分。平均强度分数报告如下:
样品溶液 | 甜味 | 苦味 | 咸味 | 鲜味 |
对照溶液 | 5.00 | 5.00 | 5.00 | 5.00 |
对照溶液+腺嘌呤(2ppm) | - | 6.33 | - | - |
对照溶液+腺嘌呤(20ppm) | 5.76 | - | 5.16 | 5.02 |
p值 | 0.053 | 0.005<sup>*</sup> | 0.282 | 0.940 |
对照溶液+鸟嘌呤(2ppm) | - | 6.50 | - | - |
对照溶液+鸟嘌呤(20ppm) | 4.80 | - | 5.06 | 4.82 |
p值 | 0.600 | <0.005<sup>*</sup> | 0.684 | 0.501 |
*在所有测试的基础味道中,腺嘌呤和鸟嘌呤仅影响苦味。
腺嘌呤和鸟嘌呤表现出类似的效果。两者都影响苦味,但对甜味、咸味或鲜味没有影响。
实施例III:鸟嘌呤的选择性酸味增强
检测并比较了腺嘌呤和鸟嘌呤对酸味的影响。分别制备了腺嘌呤和鸟嘌呤在基础溶液中的测试样品溶液(分别为5和100ppb)。
通过一组专门小组成员使用0至10的强度等级来评估每个样品的酸味,其中0=无,5=中等,10=极强。指示专门小组成员将基础溶液的强度固定为等级5。使用具有PostHoc LSD多重比较的单向ANOVA分析强度评分。平均强度分数报告如下:
样品溶液 | 强度分 | p值 |
基础溶液 | 5.00 | N/A |
腺嘌呤(5ppb) | 5.14 | 0.612 |
腺嘌呤(100ppb) | 5.73 | 0.163 |
鸟嘌呤(5ppb) | 6.44 | <0.001<sup>*</sup> |
鸟嘌呤(100ppb) | 7.08 | <0.001<sup>*</sup> |
*与腺嘌呤相比,鸟嘌呤导致酸味感觉显著增加。
腺嘌呤和鸟嘌呤对大多数基础味道(包括苦味、甜味、咸味和鲜味)表现出类似的作用。然而,鸟嘌呤表现出独特的酸味增强。因此,这种增强是高度选择性和出乎意料的。
实施例IV:在不降低pH水平的情况下增强酸味
制备柠檬酸在水中的对照样品溶液(450ppm)和鸟嘌呤核苷在基础溶液中的测试样品溶液(1.25ppm)。
将(i)基础溶液和对照样品溶液的样品对;和(ii)测试样品溶液和对照样品溶液的样品对各自以盲测和伪随机顺序提供给感官小组。基于专门小组成员给出的百分比(给样品酸味的打分)记录酸味的增强。测试结果如下:
样品溶液 | pH水平 | 专门小组成员选择(%) |
基础溶液(柠檬酸,400ppm) | 3.19 | 0 |
对照溶液(柠檬酸,450ppm) | 3.17 | 100 |
1.25ppm的鸟嘌呤核苷增强酸味且不降低pH水平。此外,增强效果大于50ppm柠檬酸的增强效果。
实施例V:鸟嘌呤核苷对其他基础味道的影响
检测并比较鸟嘌呤核苷及其相应的核苷酸,鸟嘌呤核苷5'-单磷酸(GMP)对其它基础味道的影响。如上述实施例II中那样制备甜味、苦味、咸味和鲜味的对照溶液。分别制备鸟嘌呤核苷和GMP在不同的对照溶液中的测试溶液(2或20ppm)。
通过一组专门小组成员使用0至10的强度等级来评估每个样品的味觉,其中0=无,5=中等,10=极强。指示专门小组成员将对照溶液的强度固定为等级5。使用具有PostHoc LSD多重比较的单向ANOVA分析强度分数。平均强度分数报告如下:
样品溶液 | 甜味 | 苦味 | 咸味 | 鲜味 |
对照 | 5.00 | 5.00 | 5.00 | 5.00 |
对照+GMP(2ppm) | - | 6.50 | - | - |
对照+GMP(20ppm) | 5.42 | - | 5.34 | 9.60 |
P值 | 0.274 | <0.005<sup>*</sup> | <0.05<sup>*</sup> | <0.005<sup>*</sup> |
对照+鸟嘌呤核苷(2ppm) | - | 7.00 | - | - |
对照+鸟嘌呤核苷(20ppm) | 5.52 | - | 5.22 | 4.98 |
p值 | 0.178 | <0.005<sup>*</sup> | 0.143 | 0.940 |
*鸟嘌呤核苷仅影响苦味,而GMP则增强了苦味、咸味和鲜味的感觉。
鸟嘌呤核苷及其盐GMP结构相似,对基础味道有明显不同的影响。GMP在改变更多类型的基础味道方面具有很强的效果。
实施例VI:鸟嘌呤核苷的选择性酸味增强
检测并比较鸟嘌呤核苷和GMP对酸味的影响。分别制备了GMP和鸟嘌呤核苷在基础溶液中的测试样品溶液(分别为5和100ppb)。
将样品对(GMP溶液和鸟嘌呤核苷溶液)以盲测和伪随机顺序提供给感官小组。基于专门小组成员给出的百分比(给样品酸味的打分)记录酸味的增强。使用二项式统计分析来比较每个样品对的酸味增强。显著性为95%置信区间(p<0.05)。测试结果如下:
样品对 | 结果 | p值 |
GMP vs鸟嘌呤核苷(5ppb) | 鸟嘌呤核苷溶液味道更酸 | <0.005<sup>*</sup> |
GMP vs鸟嘌呤核苷(100ppb) | 鸟嘌呤核苷溶液味道更酸 | <0.005<sup>*</sup> |
*与GMP相比,鸟嘌呤核苷导致酸味感觉显著增加。
GMP和鸟嘌呤核苷对味道改变具有不同作用。与鸟嘌呤核苷相比,GMP具有更强的作用,更能增强基础味道。然而,鸟嘌呤核苷显示出独特的酸味增强。因此,这种增强是高度选择性和出乎意料的。
实施例VII:小白菊(Chrysanthemumparthenium)提取物的制备
将经干燥和切割的小白菊地上部分(aerial parts)(可购自Monterey Bay SpiceCompany,California,US)(100g,尺寸为5至10目)用乙醇(60%体积,500mL)在60℃下提取3小时。将提取物排出并收集。重复提取步骤。合并两种提取物、过滤并干燥成粉末。将粉末(10g)悬浮在乙酸乙酯(CH3COOC2H5)(20g)或异丁醇((CH3)2CHCH2OH)(10g)中。将悬浮液在室温下搅拌3小时,然后过滤以回收粉末。在50℃下真空除去粉末中残留的乙酸乙酯或异丁醇。获得含有鸟嘌呤核苷(139ppm)和腺苷(32ppm)的小白菊提取物。
实施例VIII:生咖啡豆提取物的制备
将生咖啡豆提取物粉末(可购自Guilin Layn,Gui Lin,China)(48g)溶解在水(400g)中。使用氢氧化钠(NaOH)将溶液的pH水平调节至7。然后将溶液加热至50℃并加入Viscozyme(9.6g)。酶处理在50℃下进行48小时。通过酶的热失活终止反应。然后将反应溶液干燥,得到含有粉末形式的鸟嘌呤核苷(330ppm)和腺苷(10ppm)的生咖啡豆提取物。
实施例IX:通过植物提取物的酸味增强
研究了植物提取物如小白菊提取物对酸味的影响。制备提取物在基础溶液(15ppm)中的测试样品溶液。
使用配对比较方法进行感官评价。将使用3位数代码从而无法识别的基础溶液和测试样品溶液以盲测和伪随机顺序呈现给感官小组。基于专门小组成员给出的百分比(给样品酸味的打分)记录酸味的增强。使用二项式统计分析来分析数据。结果,据以下报道,含有小白菊提取物的测试样品溶液比基础溶液显著更酸(p<0.05)。
实施例X:在饮料中的应用
通过将糖(120g),橙汁浓缩物63°Brix(16.9g),柠檬酸钠(HOC(COONa)(CH2COONa)2)(0.25g),柠檬酸(2.15g)和黄色#6溶液(1重量%,0.25mL)加入水中以提供总体积为1L从而制备橙汁饮料。如下制备含有和不含小白菊提取物的橙汁饮料。
成分 | 对照溶液(重量%) | 测试溶液(重量%) |
橙汁饮料 | 99.85 | 99.70 |
橙味风味剂 | 0.15 | 0.15 |
在水中的小白菊提取物(1重量%) | -- | 0.15 |
感官评估由感官小组进行。测试样品被鉴定为更多汁、更新鲜、更酸、更清新且更正宗。
实施例XI:在糖果中的应用
本发明在糖果中的应用如下所示:
耐嚼糖果基料是根据申请人的专有配方制备的。感官评估由感官小组进行。测试样品被鉴定为更多汁、更酸且更持久。
实施例XII:在肉制品中的应用
本发明在肉制品中的应用如下所示:
成分 | 对照溶液(重量%) | 测试溶液(重量%) |
水 | 15.54 | 15.04 |
腌制鸡胸肉基料 | 84.46 | 84.46 |
在水中的生咖啡豆提取物(1重量%) | -- | 0.50 |
腌制鸡胸肉基料是根据申请人的专有配方制备的。感官评估由感官小组进行。测试样品被鉴定为更多汁且更有肉质(succulent)。
实施例XIII:在脆片产品中的应用
本发明在脆片产品中的应用如下所示:
成分 | 对照溶液(重量%) | 测试溶液(重量%) |
碎薯片基料 | 100 | 95.50 |
在水中的生咖啡豆提取物(1重量%) | -- | 0.50 |
使用PRINGLES基于申请人的专有配方制备碎薯片基料。感官评估由感官小组进行。含有生咖啡豆提取物的测试样品被鉴定为更多汁、更新鲜和更令人垂涎。
Claims (20)
1.一种增强消费品的酸味的方法,所述方法包括向所述消费品中添加嗅觉有效量的酸味增强剂的步骤,所述酸味增强剂选自鸟嘌呤、鸟嘌呤核苷及其混合物。
2.根据权利要求1所述的方法,其中所述嗅觉有效量以重量计为约0.1ppt至约500ppm。
3.根据权利要求1所述的方法,其中所述嗅觉有效量为约0.1ppb至约50ppm。
4.根据权利要求1所述的方法,其中所述嗅觉有效量为约1ppb至约5ppm。
5.根据权利要求1所述的方法,其中所述酸味增强剂是鸟嘌呤核苷。
6.一种组合,其包含嗅觉有效量的酸味增强剂和可食用酸,所述酸味增强剂选自鸟嘌呤、鸟嘌呤核苷及其混合物。
7.根据权利要求6所述的组合,其中所述嗅觉有效量为约0.1ppt至约500ppm。
8.根据权利要求6所述的组合,其中所述嗅觉有效量为约0.1ppb至约50ppm。
9.根据权利要求6所述的组合,其中所述嗅觉有效量为约1ppb至约5ppm。
10.根据权利要求6所述的组合,其还包含选自由聚合物、低聚物和非聚合物组成的组中的材料。
11.根据权利要求10的组合,其中所述聚合物选自聚丙烯酸酯、聚脲、聚氨酯、聚丙烯酰胺、聚酯、聚醚、聚酰胺、聚(丙烯酸酯-共-丙烯酰胺)、淀粉、二氧化硅、明胶和阿拉伯树胶、藻酸盐、壳聚糖、聚交酯、聚(三聚氰胺-甲醛)、聚(脲-甲醛)及其组合。
12.根据权利要求6所述的组合,其中所述可食用酸选自乙酸、尿囊酸、α-酮基戊二酸、抗坏血酸、天冬氨酸、苯甲酸、十六酸十八酸混合物、柠苹酸、柠檬酸、甲酸、富马酸、半乳糖醛酸、葡糖醛酸、谷氨酸、甘油酸、乙醇酸、盐酸、异柠檬酸、乳酸、lactarimic acid、乳酸异柠檬酸、苹果酸、草酰乙酸、草酸、磷酸、焦谷氨酸、吡咯烷酮羧酸、丙酮酸、奎尼酸、莽草酸、琥珀酸、硫酸、酒石酸及其混合物。
13.根据权利要求6所述的组合,其中所述酸味增强剂是鸟嘌呤核苷。
14.根据权利要求13所述的组合,其还包含腺苷。
15.一种消费品,其含有嗅觉有效量的酸味增强剂和可食用酸,所述酸味增强剂选自鸟嘌呤、鸟嘌呤核苷及其混合物。
16.根据权利要求15所述的消费品,其中所述可食用酸选自乙酸、尿囊酸、α-酮基戊二酸、抗坏血酸、天冬氨酸、苯甲酸、十六酸十八酸混合物、柠苹酸、柠檬酸、甲酸、富马酸、半乳糖醛酸、葡糖醛酸、谷氨酸、甘油酸、乙醇酸、盐酸、异柠檬酸、乳酸、lactarimic acid、乳酸异柠檬酸、苹果酸、草酰乙酸、草酸、磷酸、焦谷氨酸、吡咯烷酮羧酸、丙酮酸、奎尼酸、莽草酸、琥珀酸、硫酸、酒石酸及其混合物。
17.根据权利要求15所述的消费品,其中所述消费品选自由食品、药用组合物、膳食补充剂、营养保健品、牙科卫生组合物和化妆品组成的组。
18.根据权利要求17所述的消费品,其中所述食品是饮料,糖果,肉制品或脆片产品。
19.根据权利要求15所述的消费品,其中所述酸味增强剂是鸟嘌呤核苷。
20.根据权利要求19所述的消费品,其还包含腺苷。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662422633P | 2016-11-16 | 2016-11-16 | |
US62/422,633 | 2016-11-16 | ||
PCT/US2017/061693 WO2018093828A1 (en) | 2016-11-16 | 2017-11-15 | Novel compositions for flavor enhancement |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109936983A true CN109936983A (zh) | 2019-06-25 |
Family
ID=62146814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780068986.8A Pending CN109936983A (zh) | 2016-11-16 | 2017-11-15 | 用于增强风味的新型组合物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20190364943A1 (zh) |
EP (1) | EP3541204A4 (zh) |
CN (1) | CN109936983A (zh) |
BR (1) | BR112019007913A2 (zh) |
MX (1) | MX2019005659A (zh) |
WO (1) | WO2018093828A1 (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE707408A (zh) * | 1967-12-01 | 1968-04-16 | ||
GB1200582A (en) * | 1968-03-22 | 1970-07-29 | Ralston Purina Co | Dog food compositions |
US3778513A (en) * | 1967-08-25 | 1973-12-11 | Kyowa Hakko Kogyo Kk | Process for preparing meat extract-like seasoning |
US3830798A (en) * | 1968-03-22 | 1974-08-20 | Ralston Purina Co | Hydrolysis of ribonucleic acid containing material |
JPS6167458A (ja) * | 1984-09-11 | 1986-04-07 | Ajinomoto Co Inc | こく味調味料又はこく味の増強された食品の製法 |
US20150366251A1 (en) * | 2012-11-30 | 2015-12-24 | Symrise Ag | Food Additives Containing Glutamic Acid and Nucleotides |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07504810A (ja) * | 1991-11-27 | 1995-06-01 | バイオリサーチ・インコーポレイテツド | 特異的な可食物食味改質剤 |
TWI289044B (en) * | 2003-05-12 | 2007-11-01 | Kao Corp | Low-salt soy sauce |
MXPA06011614A (es) * | 2004-04-06 | 2007-05-04 | Quest Int | Proceso para producir preparaciones con sabor maillard. |
JP2010094112A (ja) * | 2008-10-20 | 2010-04-30 | Ito En Ltd | 野菜汁の呈味改善方法及び野菜汁の製造方法 |
WO2010108542A1 (en) * | 2009-03-25 | 2010-09-30 | Nestec S.A. | A natural taste enhancing savoury base and a process for its preparation |
US8524302B2 (en) * | 2009-11-02 | 2013-09-03 | Pepsico | Natural flavour enhancers and methods for making same |
WO2013143822A1 (en) * | 2012-03-26 | 2013-10-03 | Imax Discovery Gmbh | Adenosine as sweetness enhancer for certain sugars |
KR20220000919A (ko) * | 2013-01-11 | 2022-01-04 | 임파서블 푸즈 인크. | 소비재의 풍미 및 향미 프로파일에 영향을 미치는 방법 및 조성물 |
CN104996963B (zh) * | 2015-07-08 | 2018-06-15 | 广东肇庆星湖生物科技股份有限公司 | 一种复合增味基的制备方法及所得的产品 |
-
2017
- 2017-11-15 CN CN201780068986.8A patent/CN109936983A/zh active Pending
- 2017-11-15 WO PCT/US2017/061693 patent/WO2018093828A1/en unknown
- 2017-11-15 BR BR112019007913A patent/BR112019007913A2/pt not_active Application Discontinuation
- 2017-11-15 MX MX2019005659A patent/MX2019005659A/es unknown
- 2017-11-15 US US16/461,598 patent/US20190364943A1/en not_active Abandoned
- 2017-11-15 EP EP17871347.5A patent/EP3541204A4/en not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3778513A (en) * | 1967-08-25 | 1973-12-11 | Kyowa Hakko Kogyo Kk | Process for preparing meat extract-like seasoning |
BE707408A (zh) * | 1967-12-01 | 1968-04-16 | ||
GB1200582A (en) * | 1968-03-22 | 1970-07-29 | Ralston Purina Co | Dog food compositions |
US3830798A (en) * | 1968-03-22 | 1974-08-20 | Ralston Purina Co | Hydrolysis of ribonucleic acid containing material |
JPS6167458A (ja) * | 1984-09-11 | 1986-04-07 | Ajinomoto Co Inc | こく味調味料又はこく味の増強された食品の製法 |
US20150366251A1 (en) * | 2012-11-30 | 2015-12-24 | Symrise Ag | Food Additives Containing Glutamic Acid and Nucleotides |
Also Published As
Publication number | Publication date |
---|---|
MX2019005659A (es) | 2019-07-04 |
EP3541204A1 (en) | 2019-09-25 |
US20190364943A1 (en) | 2019-12-05 |
EP3541204A4 (en) | 2020-08-12 |
WO2018093828A1 (en) | 2018-05-24 |
BR112019007913A2 (pt) | 2019-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104144605A (zh) | 使用莱鲍迪苷c作为增味剂的方法 | |
CN104939021A (zh) | 用于增强甜味的柚皮素及其盐 | |
CN102573521A (zh) | 包括莱鲍迪苷a或d的甜度增强剂 | |
CN105307502A (zh) | 莱鲍迪苷e以及用莱鲍迪苷e增甜的食品 | |
JP7003249B2 (ja) | 芳香組成物 | |
CN108697133A (zh) | 3-(3-羟基-4-甲氧基-苯基)-1-(2,4,6-三羟基-苯基)丙-1-酮的用途 | |
EP3524062B1 (en) | Cyclohexanecarboxylic acids for selective taste masking | |
EP3108754B1 (en) | Novel triterpene glycosides as sweeteners or sweetener enhancer | |
WO2019180140A2 (en) | Flavored articles having a reduced ph | |
US20200305483A1 (en) | Sourness enhancers comprising a cyclohexanecarboxylic acid | |
JP7330192B2 (ja) | 甘味料または甘味増強剤としての新規なトリテルペン-グリコシド | |
JP2018518953A (ja) | 甘味料又は甘味増強剤としての天然スチルベンの使用 | |
CN117098460A (zh) | 包含罗汉果苷的甜味剂组合物及其用途 | |
CN116963609A (zh) | 包含罗汉果苷的甜味剂组合物及其用途 | |
JP2023525663A (ja) | 苦味遮断薬および使用の関連方法 | |
CN102497787A (zh) | 有机化合物中或与之相关的改进 | |
JP2016116510A (ja) | トランスグルコシル化ルブス・スアウィッシムスエキス並びに調製及び使用の方法 | |
CN109936983A (zh) | 用于增强风味的新型组合物 | |
JP2015077124A (ja) | 飲料 | |
BR112020012819B1 (pt) | Artigos saborizados que têm um ph reduzido | |
CN104686988A (zh) | 作为天然产品甜度增强剂的莱鲍迪甙c及其立体异构体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190625 |
|
WD01 | Invention patent application deemed withdrawn after publication |